These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8757020)

  • 61. Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography.
    Chase TN; Foster NL; Fedio P; Brooks R; Mansi L; Di Chiro G
    Ann Neurol; 1984; 15 Suppl():S170-4. PubMed ID: 6611118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In Alzheimer's disease, hypometabolism in low-amyloid brain regions may be a functional consequence of pathologies in connected brain regions.
    Klupp E; Förster S; Grimmer T; Tahmasian M; Yakushev I; Sorg C; Yousefi BH; Drzezga A
    Brain Connect; 2014 Jun; 4(5):371-83. PubMed ID: 24870443
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism.
    Slansky I; Herholz K; Pietrzyk U; Kessler J; Grond M; Mielke R; Heiss WD
    Neuroradiology; 1995 May; 37(4):270-7. PubMed ID: 7666958
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correction of positron emission tomography data for cerebral atrophy.
    Herscovitch P; Auchus AP; Gado M; Chi D; Raichle ME
    J Cereb Blood Flow Metab; 1986 Feb; 6(1):120-4. PubMed ID: 3484745
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association between cerebral metabolism and Rey-Osterrieth Complex Figure Test performance in Alzheimer's disease.
    Melrose RJ; Harwood D; Khoo T; Mandelkern M; Sultzer DL
    J Clin Exp Neuropsychol; 2013; 35(3):246-58. PubMed ID: 23387510
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frontal lobe hypometabolism and depression in Alzheimer's disease.
    Hirono N; Mori E; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
    Neurology; 1998 Feb; 50(2):380-3. PubMed ID: 9484357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neuroanatomical correlates of low body weight in Alzheimer's disease: a PET study.
    Hu X; Okamura N; Arai H; Higuchi M; Maruyama M; Itoh M; Yamaguchi K; Sasaki H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1285-9. PubMed ID: 12502015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in brain functional homogeneity in subjects with Alzheimer's disease.
    Volkow ND; Zhu W; Felder CA; Mueller K; Welsh TF; Wang GJ; de Leon MJ
    Psychiatry Res; 2002 Feb; 114(1):39-50. PubMed ID: 11864808
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
    Cutler NR; Haxby JV; Duara R; Grady CL; Moore AM; Parisi JE; White J; Heston L; Margolin RM; Rapoport SI
    Neurology; 1985 Nov; 35(11):1556-61. PubMed ID: 3877253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease.
    Heiss WD; Kessler J; Slansky I; Mielke R; Szelies B; Herholz K
    Ann N Y Acad Sci; 1993 Sep; 695():327-31. PubMed ID: 8239307
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional imaging patterns in Alzheimer's disease. Relationships to neurobiology.
    Jagust WJ
    Ann N Y Acad Sci; 1996 Jan; 777():30-6. PubMed ID: 8624103
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unchanged type 1 metabotropic glutamate receptor availability in patients with Alzheimer's disease: A study using
    Ishibashi K; Miura Y; Toyohara J; Ishiwata K; Ishii K
    Neuroimage Clin; 2019; 22():101783. PubMed ID: 30909027
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer's Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study.
    Shigemoto Y; Sone D; Imabayashi E; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Sato N; Matsuda H
    Front Aging Neurosci; 2018; 10():223. PubMed ID: 30072890
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regional changes of cortical mean diffusivities with aging after correction of partial volume effects.
    Jeon T; Mishra V; Uh J; Weiner M; Hatanpaa KJ; White CL; Zhao YD; Lu H; Diaz-Arrastia R; Huang H
    Neuroimage; 2012 Sep; 62(3):1705-16. PubMed ID: 22683383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.